文献速递泌尿生殖技术与安全PETMRCT

前列腺特异性膜抗原正电子发射断层显像与常规影像模态在前列腺癌生化复发检测中的比较及人工智能作用评估:系统综述与Meta分析

Comparison of Prostate-Specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities in the Detection of Biochemical Recurrence of Prostate Cancer and Assessment of the Role of Artificial Intelligence: A Systematic Review and Meta-analysis.
PubMed 文献 · Acad Radiol · 2025-09-20

该系统综述与Meta分析纳入67项研究共7637例患者,比较PSMA PET与常规影像检测前列腺癌生化复发的诊断效能。PSMA PET总体诊断准确率高于mpMRI、CT和AI测试集(0.89 vs 0.71、0.45和0.76,P<0.01),局部复发mpMRI优于PSMA PET和CT(0.93 vs 0.84和0.77,P<0.01)。AI测试集汇总敏感度0.77、特异度0.76、DOR 10.39、AUC 0.79,异质性限制结论外推。

要点

  • PSMA PET总体诊断准确率0.89,高于mpMRI的0.71、CT的0.45和AI测试集的0.76(P<0.01)。
  • 局部复发mpMRI准确率0.93,优于PSMA PET的0.84和CT的0.77(P<0.01)。
  • 骨转移PSMA PET准确率0.95,优于mpMRI的0.85、CT的0.81和骨扫描的0.80(P<0.05)。

核心结论

  • PSMA PET在总体复发、局部复发、骨转移和内脏转移检测中优于mpMRI和CT,而mpMRI对局部复发更有效;AI显示潜在诊断效能,但异质性和验证有限,需进一步研究支持常规临床使用。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Web of Science、Cochrane Library和Scopus,初次检索2025年5月7日、更新至2025年7月28日,纳入比较PSMA PET与常规影像及评估AI检测前列腺癌生化复发的研究,采用QUADAS-2评估研究质量,双变量随机效应模型汇总诊断准确率和检出率。

诊断标准与关键数值

  • 共纳入67项研究7637例患者;PSMA PET总体诊断准确率0.89 vs mpMRI 0.71、CT 0.45、AI测试集0.76(P<0.01);局部复发mpMRI 0.93 vs PSMA PET 0.84、CT 0.77(P<0.01);淋巴结转移PSMA PET 0.89 vs mpMRI 0.79、CT 0.72(P<0.05);骨转移PSMA PET 0.95 vs mpMRI 0.85、CT 0.81、骨扫描0.80(P<0.05);内脏转移PSMA PET 0.96 vs mpMRI 0.89(P=0.23)、CT 0.78(P<0.05);AI检测生化复发纳入21项研究3113例样本,汇总敏感度0.77、特异度0.76、DOR 10.39、AUC 0.79。

临床应用与阅片要点

  • 作者认为PSMA PET在总体、局部、骨和内脏转移检测中优于mpMRI和CT,mpMRI对局部复发更有效,AI显示潜在诊断效能;异质性和有限验证提示需进一步研究支持常规临床使用。

局限性

  • 异质性限制研究结论的普遍性。
  • 尽管结果有前景,异质性和有限验证突出需进一步研究支持常规临床使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: We conducted a systematic review and meta-analysis to assess and compare the diagnostic performance of prostate-specific membrane antigen positron-emission tomography (PSMA PET) with conventional imaging modalities in detecting biochemical recurrence of prostate cancer, and to assess the role of artificial intelligence in this context.

MATERIALS AND METHODS: A comprehensive search of PubMed, Embase, Web of Science, the Cochrane Library, and Scopus was conducted for studies, initially on May 7, 2025, and updated on July 28, 2025. Studies that compared PSMA PET with conventional imaging and assessed artificial intelligence for detecting biochemical recurrence of prostate cancer were considered. The QUADAS-2 technique was employed to evaluate study quality. Diagnosis accuracy and detection rates were aggregated utilizing a bivariate random-effects model.

RESULTS: A total of 7637 patients from 67 studies were included. PSMA PET demonstrated significantly higher overall diagnostic accuracy for biochemical recurrence of prostate cancer compared to mpMRI, CT, and AI test sets, with accuracy values of (0.89 vs. 0.71, 0.45, and 0.76, P<0.01). For local recurrence, mpMRI outperformed PSMA PET and CT (0.93 vs. 0.84 and 0.77, P<0.01). PSMA PET was superior in detecting lymph node metastasis than mpMRI and CT (0.89 vs. 0.79 and 0.72, P<0.05). For bone metastasis, PSMA PET outperformed mpMRI, CT, and Bone scan (0.95 vs. 0.85, 0.81, and 0.80, P<0.05). For visceral metastasis, PSMA PET outperformed mpMRI (0.96 vs. 0.89, P=0.23), and CT (0.96 vs. 0.78, P<0.05). 21 studies involving 3113 samples were included to evaluate the performance of artificial intelligence in detecting biochemical recurrence of prostate cancer. The pooled sensitivity, specificity, DOR, and AUC of AI test sets in detecting biochemical recurrence of prostate cancer were 0.77, 0.76, 10.39, and 0.79. Heterogeneity limits the generalizability of our findings.

CONCLUSION: PSMA PET outperformed mpMRI and CT in detecting overall, local recurrence, bone, and visceral metastasis, while mpMRI was more effective for local recurrence. While AI exhibits potential diagnostic efficacy. Despite promising results, heterogeneity and limited validation highlight the need for further research to support routine clinical use.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang H, Xie C, Huang C, et al. Comparison of Prostate-Specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities in the Detection of Biochemical Recurrence of Prostate Cancer and Assessment of the Role of Artificial Intelligence: A Systematic Review and Meta-analysis. Acad Radiol. 2025. PMID: 40976756. doi:10.1016/j.acra.2025.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。